Low-Dose Dextromethorphan for the Treatment of Fibromyalgia Pain: Results from a Longitudinal, Single-Blind, Placebo-Controlled Pilot Trial

Mechanism underlying β2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells

(2019) Monika Sharma et al.   JOURNAL OF NEUROIMMUNOLOGY

Defective Endogenous Pain Modulation in Fibromyalgia: A Meta-Analysis of Temporal Summation and Conditioned Pain Modulation Paradigms

(2018) Anthony Terrence O'Brien et al.   JOURNAL OF PAIN

The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders

(2018) Denise K. Patten et al.   PHARMACOTHERAPY

Brain glial activation in fibromyalgia – A multi-site positron emission tomography investigation

(2018) Daniel S. Albrecht et al.   BRAIN BEHAVIOR AND IMMUNITY

Responses to Slowly Repeated Evoked Pain Stimuli in Fibromyalgia Patients: Evidence of Enhanced Pain Sensitization

(2017) Pablo de la Coba et al.   PAIN MEDICINE

Opioid Use in Fibromyalgia

(2016) Don L. Goldenberg et al.   MAYO CLINIC PROCEEDINGS

2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria

(2016) Frederick Wolfe et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Long-term Evaluation of Opioid Treatment in Fibromyalgia

(2015) Xiaomei Peng et al.   CLINICAL JOURNAL OF PAIN

The Effects of Dextromethorphan on Driving Performance and the Standardized Field Sobriety Test

(2015) Paul J. Perry et al.   JOURNAL OF FORENSIC SCIENCES

Sickness: From the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons

(2015) David Chun-Hei Poon et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Changes in Metabolites after Treatment with Memantine in Fibromyalgia. A Double-Blind Randomized Controlled Trial with Magnetic Resonance Spectroscopy with a 6-month Follow-up

(2014) Nicolás Fayed et al.   CNS Neuroscience & Therapeutics

Determining the neuroprotective effects of dextromethorphan in lipopolysaccharide-stimulated BV2 microglia

(2014) WENJING CHENG et al.   Molecular Medicine Reports

The Hospital Anxiety and Depression Scale

(2014) A. F. Stern   OCCUPATIONAL MEDICINE-OXFORD

Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up

(2014) Bárbara Olivan-Blázquez et al.   PAIN

Slow Temporal Summation of Pain for Assessment of Central Pain Sensitivity and Clinical Pain of Fibromyalgia Patients

(2014) Roland Staud et al.   PLoS One

Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI

(2014) Barbara Cagnie et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

A Study of Potential Pharmacokinetic and Pharmacodynamic Interactions between Dextromethorphan/Quinidine and Memantine in Healthy Volunteers

(2013) Laura E. Pope et al.   CLINICAL DRUG INVESTIGATION

Development of the Stanford Expectations of Treatment Scale (SETS): A tool for measuring patient outcome expectancy in clinical trials

(2012) Jarred Younger et al.   Clinical Trials

Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans

(2012) Lawrence P. Carter et al.   DRUG AND ALCOHOL DEPENDENCE

Dextromethorphan inhibition of voltage-gated proton currents in BV2 microglial cells

(2012) Jin-Ho Song et al.   NEUROSCIENCE LETTERS

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

(2012) Chad J. Reissig et al.   PSYCHOPHARMACOLOGY

Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: A randomized, prospective, double blind, active placebo-controlled trial

(2011) Ingeborg Noppers et al.   EUROPEAN JOURNAL OF PAIN

Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord

(2011) Olga V. Chechneva et al.   NEUROBIOLOGY OF DISEASE

Effect of dextromethorphan on human Kv1.3 channel activity: Involvement of C-type inactivation

(2010) Jun-Ho Lee et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Fibromyalgia-pathways and neurotransmitters

(2010) Stephen M. Stahl   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity

(2010) Frederick Wolfe et al.   ARTHRITIS CARE & RESEARCH

Elevated excitatory neurotransmitter levels in the fibromyalgia brain

(2010) Richard E Harris   ARTHRITIS RESEARCH & THERAPY

Microglial Physiology: Unique Stimuli, Specialized Responses

(2009) Richard M. Ransohoff et al.   Annual Review of Immunology

The Proinflammatory Action of Microglial P2 Receptors Is Enhanced in SOD1 Models for Amyotrophic Lateral Sclerosis

(2009) N. D'Ambrosi et al.   JOURNAL OF IMMUNOLOGY

The Multifaceted Profile of Activated Microglia

(2009) Marina A. Lynch   MOLECULAR NEUROBIOLOGY

Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study

(2009) Jarred Younger et al.   PAIN MEDICINE

Brain activity associated with slow temporal summation of C-fiber evoked pain in fibromyalgia patients and healthy controls

(2008) Roland Staud et al.   EUROPEAN JOURNAL OF PAIN